US patent reform bill raises concerns among device makers
This article was originally published in Clinica
Executive Summary
The US Medical Device Manufacturers Association (MDMA) and other groups representing manufacturers and academic researchers are urging Congress to reconsider major components of a bill that would radically revise the US patent system.